HRiA is designing an evaluation of the Alzheimer’s Association Dementia Care Coordination program. This four-year project, funded by Merck, is evaluating the DCC program which is designed to improve access and care for persons living with Alzheimer’s disease and their caregivers. The DCC program has three broad aims: 1) to improve access to an early and comprehensive course of care, in order improve the management of the disease for the person with dementia and the caregiver; 2) to deliver coordinated care which includes the individual’s health care provider, the Alzheimer’s Association clinical team, and the caregiver, to fill care gaps and implement a successful model of ongoing care coordination; and 3) to provide direct access to the Alzheimer’s Association’s full range of resources for health care providers to assist them in the management of their patients with Alzheimer’s disease and other dementias, with the goal of improving caregiver support, performance, and confidence. The Alzheimer’s Association is expanding its DCC program in Massachusetts and adding health care partners in three states: Rhode Island, Maine, and New Hampshire. HRiA is facilitating a process with Alzheimer’s Association leadership to identify an evaluation design and metrics for examination in the evaluation. The project began in July 2018 and will be completed by June 2022.
Client: Foundations and Bank Trusts, Health Care (including hospitals and health systems)
Services Provided: Research & Evaluation
Technical Expertise: Public Health-Health Care Integration, Other